# SUCRALOSE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid1040245
Categories: beauty, cleaning, food, pharma
Functions: Flavouring and nutrient, Fragrance, Softener and conditioner
Identifier: DTXSID1040245

> SUCRALOSE is used as flavouring and nutrient / fragrance. EPA CPDat observed this chemical in 294 composition records across product categories including Personal care, Food and drug. Assessed from 28 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 294 composition records across product categories including Personal care, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 294 composition records across product categories including Personal care, Food and drug. EPA CPDat classifies this chemical for functional uses including Softener and conditioner, Flavouring and nutrient, Fragrance.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 70 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: FILM; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 33 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Potency: 5.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 23 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 115 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 414 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 400 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 383 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 16 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 45 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 28 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EFFERVESCENT; Maximum daily exposure: 1080 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 65 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 12 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 2 active drug products and 2 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._